Related Experiment Video

Updated: Aug 26, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

[Rhein induces apoptosis in cancer cells and shows synergy with mitomycin]

Y H Huang1, Y S Zhen

  • 1Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Pekin Union Medical College, Beijing 100050, China.

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|February 15, 2003
PubMed
Abstract

Insights

Rhein, a plant compound, effectively inhibits tumor cell growth and induces apoptosis. Its combination with mitomycin C (MMC) shows synergistic effects, enhancing cancer chemotherapy potential.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Context:

  • Cancer remains a leading cause of mortality worldwide, necessitating novel therapeutic strategies.
  • Natural compounds are increasingly investigated for their anti-cancer properties.
  • Rhein, an anthraquinone derived from traditional Chinese medicine, exhibits potential anti-tumor activities.

Purpose:

  • To evaluate the apoptosis-inducing and growth-inhibitory effects of rhein.
  • To assess the combined efficacy of rhein and mitomycin C (MMC) on various cancer cell lines.
  • To elucidate the mechanisms underlying rhein's anti-cancer action, including effects on DNA synthesis and nucleoside transport.

Summary:

  • Rhein demonstrated significant dose-dependent inhibition of proliferation in KB, BEL-7402, and MCF-7 cancer cell lines.
  • Rhein induced apoptosis in KB cells, with a notable increase in apoptotic cells observed over 96 hours.
  • The combination of rhein and MMC exhibited synergistic anti-cancer effects, significantly enhancing apoptosis induction across all tested cell lines.

Impact:

  • Rhein acts as a potent biochemical modulator with potential applications in cancer chemotherapy.
  • The synergistic interaction between rhein and MMC suggests a promising combination therapy for various cancers.
  • Further research into rhein-based therapies could lead to novel treatments with improved efficacy and reduced side effects.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...